Dermira, inc. (DERM)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Collaboration revenue from a related party

-

-

-

-

7,300

-

-

Total revenue

42,339

4,541

22,585

7,300

7,300

-

-

Costs and operating expenses:
Cost of sales

1,176

-

-

-

-

-

-

Research and development

80,547

104,409

83,166

66,831

30,710

17,937

17,055

Acquired in-process research and development

891

128,555

-

-

-

-

-

Selling, general and administrative

172,581

71,903

30,043

17,721

8,288

4,366

3,148

Impairment of intangible assets

1,126

-

-

2,394

-

-

-

Total costs and operating expenses

256,321

304,867

113,209

86,946

38,998

22,303

20,203

Loss from operations

-213,982

-300,326

-90,624

-79,646

-31,698

-22,303

-20,203

Interest and other income, net

7,887

5,205

1,540

896

7

-38

-51

Interest expense

15,639

8,140

-

147

153

9

-

Loss on extinguishment of debt

-

-

-

-124

-

-

-

Loss before taxes

-221,734

-303,261

-89,084

-79,021

-31,844

-22,350

-20,254

Benefit for income taxes

-194

0

0

-622

31

0

0

Net loss

-221,540

-303,261

-89,084

-78,399

-31,875

-22,350

-20,254

Net loss per share, basic and diluted

-5.27

-7.48

-2.70

-2.93

-4.96

-27.03

-27.99

Weighted-average common shares used to compute net loss per share, basic and diluted

42,003

40,562

33,045

26,727

6,426

826

723

Product Sales
Total revenue

2,960

-

-

-

-

-

-

Collaboration and License Revenue
Total revenue

39,379

4,541

-

-

-

-

-